chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt nausea and fatigue the next am starting at 7 when he woke, had continued through day till he reported at 12:30 pm that he felt heart pounding in chest for about 10 seconds, and wanted blood pressure to be checked- 145/89- pulse 92. Stated he felt better, symptoms resolved 2 hours later after he ate and drank 2 bottles of water.
Numbness of nose & upper lip, shortness of breathe, anxiety, heart palps, coughing within 14 minutes of injections.
having numbness from her shoulder, neck, cheek and left thigh; having numbness from her shoulder, neck, cheek and left thigh; having numbness from her shoulder, neck, cheek and left thigh; having numbness from her shoulder, neck, cheek and left thigh; The numbness is from the left side from the injection site.; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as a DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history included covid-19 from an unknown date and unknown if ongoing. Reporter stated that she had COVID before. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced having numbness from her shoulder, neck, cheek and left thigh and the numbness is from the left side from the injection site. Reporter stated that she has weird symptoms that is not on the sheet that was given to her from the pharmacy. Reporter stated that she is having numbness from her shoulder, neck, cheek and left thigh. Reporter wanted to know if these are commonly reported side effects. The numbness was from the left side from the injection site. Reporter also stated that she had COVID before. She reported that, she was having numbness from her shoulder to her neck to her cheek on the left side. She was interested in knowing if its common. Her doctor thought there was aluminum in the vaccine. Outcome of all the events were unknown.
headache; Muscle aches; Chills; 102.5 fever; This is a spontaneous report from a contactable Nurse. A 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EJ1685), via an unspecified route of administration on 28Dec2020 09:00 at Arm Left at single dose for COVID-19 immunisation.  Medical history included Low thyroid, Covid (diagnosed with COVID-19: Yes). Concomitant medication included levothyroxine sodium (SYNTHROID).  The patient experienced muscle aches, chills, headache, 102.5 fever on 28Dec2020 18:00. All events were non serious. No treatment was received. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. The patient underwent lab tests and procedures which included body temperature: 102.5 on 28Dec2020.  The outcome of the events was resolved in Dec2020.  No follow up attempts are possible. No further information is expected.
Received 0.5 ml dose as booster dose instead of 0.25 ml dose of Moderna on Friday 11/19. Pt reports he is doing fine, denies symptoms at this time during 11/24 and 11/26 f/u calls.
cough; sore throat; Flu; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     Concomitant products included GABAPENTIN for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu). At the time of the report, COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was High blood pressure med.  The treatment medication was unknown.
The afternoon after the first shot I was feeling very tired and in the afternoon my Lymphs were very swollen and it continued like that for almost 2 weeks. I had periods with intense fatigue, pain over the lymph nodes, and a fever of 99°.  The 2 weeks passed by and the lymph nodes were less swollen so I couldn't feel them beating like before. But then, the pain in my legs started. This was 2 weeks ago, my whole body ached. Like I had the most terrible flu. Then, a week ago, my joints are very painful, that includes toes, ankles, knees, shoulders, elbows, hands, fingers, and my cervical joint. My energy has been draining and everything feels bad like Life has been abandoning me.  I went to the doctor on May 18th (when the joints have just started to ache but my body was tired and very very low of energy) and I had blood tests, the funny thing is that I have been gaining weight but the result of the tests show that my blood red cell count is lower than average showing slight anemia, the creatinine, and blood sugar are also lower than average.  When I had the appointment with the doctor the nurses tried to measure my blood pressure and it was extremely low, 75/49 they tried to do it several times and the results were the same. Since then I have been measuring my blood pressure and is as max as 90/61. The other blood tests don't show infection or anything else, giving no explanation to my current state.  I consulted a friend's doctor yesterday and he told me that I might be suffering an adverse effect of the Vaccine. Last week I felt very ill so I missed my appointment for the second dose of Moderna, the max time to get the second dose is this week and I think I might not be able to get it.   I am really worried because due to this I am suffering illness that apparently can not be treated or has no cause. I have tried painkillers but those don't seem to be enough for the discomfort.  I can't keep going with my daily life, I have no strength and feel not good at all.
A report has been received from a Health Professional concerning an Adult, subject of unknown gender, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 09-Oct-2013. It was reported that on 09-Oct-2013 patient over 49 years old received FLUMIST. FLUMIST quadrivalent (intranasal) was discontinued on 09-Oct-2013. The outcome of the event of patient over 49 years old received FLUMIST is unknown. The report was considered to be non-serious.
This spontaneous report was received from a physician via company representative and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 17-OCT-2014, the patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 "10 Single DS 0.5 ml LVIs 10SDV", lot # K004148, expiration date 10-MAY-2015 (route was not reported). This vaccine was improperly stored exposed to two temperature excursions, one for a sum of 72 hours at a highest temperature recorded of 47 degrees F (8.333333333 degrees C), and the other for a sum of 72 hours at a lowest temperature recorded of 34 degrees F (1.111111111 degrees Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator(R)". No adverse effects were reported. There was no product quality complained involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a medical assistant, concerning a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 19-MAY-2017, the patient was vaccinated with an improperly stored dose of ROTATEQ with lot # M025568 and expiration date on 07-NOV-2017 (strength and dose were not reported) for prophylaxis. The storage temperature was reported as 47 to 77 degrees Fahrenheit (°F) for a time frame of 7 hours and 15 minutes; but there was a previous temperature excursion reported, with a temperature of 32°F to 35°F for 10 hours. No adverse effects were reported. This is one of several reports received from the same source. No product quality complaint (PQC) was involved. Additional information has been requested.; Sender's Comments: US-009507513-1706USA002269: US-009507513-1706USA002268: US-009507513-1706USA002266: US-009507513-1705USA011335:
Redness noted at site of injection - size of "grapefruit"  No tenderness, no itching.
Vomiting, chills, and body aches began the morning after receiving the vaccine (about 20 hours after receiving). Vomiting resolved spontaneously after 1 hour. Chills and body aches for the remainder of the morning/afternoon, treated with Tylenol.
Received the vaccine on 12/30/2020, I had sore arm and slight itchy arm for 2 days.  On 1/6/21 my arm started feeling itchy, a slight burn and turned red around the injection site.
Dizziness, fatigue, cough, and COVID positive on 9/30/21.    The patient is a 72 yo male who presents with dizziness and COVID 19 infection.   Comorbidities include HTN, hyperlipidemia, prostate cancer s/p radiation (completed May 2019 followed by androgen supression therapy completed Oct 2019, last PSA <0.1 on 5/10/21), peripheral neuropathy, depression, anxiety, and prior ischemic stroke (Oct 2020, no residual deficits) with left carotid artery occlusion s/p right carotid stent placement on 11/2/20. Prior COVID 19 vaccine (Pfizer) completed on 2/24/21.    Patient presented to ED due to episode of near syncope earlier today. Patient reported feeling tired, having a cough, and had planned to have a booster dose of vaccine but has not been able to do it yet. While walking to the bathroom this morning, he felt dizzy, had to lower himself to the floor, was diaphoretic, and slow to respond. During this episode patient denied any chest pain, shortness of breath, palpitations, loss of consciousness, and seizures.
This non-serious spontaneous case, initially received from other non-health professional (consumer) on 12-Oct-2018, concerning a female patient of an unspecified age. The patient was allergic to formaldehyde. On an unspecified date in 2014, the patient was administered Influenza vaccine (dose, route of administration, anatomical location, batch number, manufacturer, trade name and expiry date: not reported). On the same day, within 30 minutes of vaccination, the patient developed swelling in arm, shortness of breath and chest pain that radiated to her shoulder. On an unspecified date, the patient went to a walk-in clinic where she was given some unspecified medications. The patient was not having any breathing problems when she was released from the clinic. On an unspecified date, the patient had recovered from the event shortness of breath. At the time of this report, the outcome of other events was not reported. The reporter considered the events as related to suspect vaccine. Follow up received by other non-health professional on 31-Oct-2018: The outcome of the event shortness of breath was updated from not reported to recovered. It was reported that the patient did not give her age or date of birth, after that she was seen in the clinic and they gave her medications. When the patient was released, she was not having any breathing problems. The narrative was amended accordingly. Non-significant follow up received from other non-health professional on 16-Nov-2018: No new information received. Hence, no changes were made in the narrative.
no adverse events reported - however, patient received both doses of the vaccine at the age of 17 when it is only approved for 18 and older.
dizzy; started to convulse, convulsions; fainted; blacked out; Seriousness Criteria- Medically significant  Initial information received on 26-Apr-2019 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves a 12 years old female patient who started to convulse, convulsions, fainted and was dizzy, while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications not reported.   On 26-Apr-2019, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U6213AA (Exp. Date not reported) via unknown route in the right arm.  On 26-Apr-2019, the patient started to convulse (convulsions) (seizure), fainted (syncope) with blacked out (loss of consciousness) 5 minutes following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. These event were assessed as medically significant.  On an unknown date, the patient was dizzy (dizziness) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. It was also reported patient was supposed to get other vaccine but she didn't get it because an ambulance came to pick her up take her to the hospital. She states that she was told the other vaccine she was supposed to get was prone to the same symptoms.  It was reported that, patient had taken to the hospital via ambulance.  Patient had blood work and test done.  Final diagnosis was fainted, started to convulse, convulsions and dizzy.   It was not reported if the patient received any corrective treatment.  At the time of reporting, the patient was not recovered from dizziness and for rest all events outcome was not reported.  List of documents held by sender: none.; Sender's Comments: This case concerns 12 years old female patient who developed syncope and seizure 5 minutes after vaccination and dizziness unknown time after vaccination with ADACEL. The time to onset is compatible for syncope and seizure. However, patient's medical condition at the time of vaccination and lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
next morning p/vax; pt would shake for awhile but ok p/up for awhile lasted @ 1 wk;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 30Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 19Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 18Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 41 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Crohn's Disease" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Received 2nd vaccine on 01/24/21.  woke up on 02/03/21 and could not talk or walk. Very weak. Admit to Medical Center. tx to Hospital on 02/12/21. Was treated with steroids for dx of Autoimmune Encephalitis. Tx to rehab center on 02/24/21 .  discharged home  04/30/21.
On 10/11/2007 child's Left arm became hot and red.  Area of redness was 4 inches by 4 inches.  Mom compared area to "like a welt, but hot".  Child was treated at home with OTC Benadryl.  On 10/12/07 he saw a physician at the clinic.  The arm remained red and hot.  He was instructed to ice the arm every 2 hours for 20 minutes.  He was to return to the clinic if the arm became pus filled.  No pus was evident at any time. No medications were given or ordered by the physician.
Itchy eyes & yellow discharge from eye, pounding heart, hard to breath, probable mild allergic rxn;
Breakthrough case admission after 3 vaccines Moderna 2/26/21 Lot# 025A21A;  Moderna 3/26/21 Lot# 028A21A;  Moderna 10/29/21 Lot# 014F21A
Blood clots; had strokes; This is a spontaneous report from a Pfizer-sponsored program. This is one of three reports. A non-contactable consumer reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blood clots and had strokes on an unspecified date after vaccination. The reporter also stated that 3 members of his family experienced the same events after vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101211992 Same reporter and drug, different patient;US-PFIZER INC-202101211993 Same reporter and drug, different patient
Redness, swelling, systemic infection.  Pt was seen in the hospital, treatment unknown.
First vaccine 2/18/21, raised rashinner arms, arm pits, body sides,stomach inner thighs. After seconddose moved to upper thighs and back; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Feb2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. The patient had no known allergies. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) for unknown indications and duration. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced rash on the inner arms, arm pits, body sides, stomach inner thighs after receiving the first dose. On 23Feb2021, the patient experienced rash on the upper thighs and back. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received first steroid shot and on 29Mar2021, the patient had taken prednisone p (MANUFACTURER UNKNOWN) as a treatment for the adverse event.  The clinical outcome of the events generalized rash was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
ROUGH WITH IMMUNE RESPONSE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 08-APR-2021, the subject experienced rough with immune response. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rough with immune response on APR-2021. This report was non-serious.
Father called stating his daughter had chicken pox, fever and itching. Pox cover chest, head, arms, pubic, anal area, face and stomach; temp 101 deg. F.
fever 102 ax 48 hrs p/immun; pt devel fever of 102 at 48 hrs p/vax, died 2 days p/fever started; MDs think death was attribut to Opitz syndrome;
Swelling of lymph node right armpit after booster; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph node right armpit after booster) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 018B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (Swelling of lymph node right armpit after booster). At the time of the report, LYMPHADENOPATHY (Swelling of lymph node right armpit after booster) had not resolved.            No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-028549 (Patient Link).
Injection given 10/23/06. When she went to bed site painful, no redness or swelling. Has used ice packs and Tylenol. Seen on 10/25/06 by PAC to continue ice packs, Tylenol and call nurse in 48 hours (on Friday 10/27/06).
Tested positive for COVID-19; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 39-year-old female patient who received mRNA-1273 (Moderna        On 30-Dec-2020 at 1:36 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Jan-2021 at 9:39 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 18-Nov-2021 at 11:57 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 02-Feb-2022, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient did not have allergies to medications, food, and other products. Patient had no acute illnesses at the time of vaccination and up to one month before. Had no chronic or long-standing health conditions. No prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination and/or at the time of the adverse event.  No treatment information was provided.      Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2022: Follow up received contains no newinformation.
Allergic reaction to TB shot. Swelling in the arm and pain. Also caused headaches and some back pain near the area. 9x6cmm is the size rash/bump.